KI-Beratung Beta

  • Produktbild: Laser-Driven Particle Acceleration Towards Radiobiology and Medicine
  • Produktbild: Laser-Driven Particle Acceleration Towards Radiobiology and Medicine
- 10%

Laser-Driven Particle Acceleration Towards Radiobiology and Medicine

10% sparen

95,99 € UVP 106,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

13.05.2016

Abbildungen

XVIII, 320 p. 106 illus., 78 illus. in color.

Herausgeber

Antonio Giulietti

Verlag

Springer

Seitenzahl

320

Maße (L/B/H)

24,1/16/2,4 cm

Gewicht

676 g

Auflage

1st ed. 2016

Sprache

Englisch

ISBN

978-3-319-31561-4

Beschreibung

Portrait


Antonio Giulietti is a physicist operating at INO (National
Institute of Optics, Italy). He has been CNR Research Director and Head of the Unit
"Adriano Gozzini" of INO. He founded ILIL (Intense Laser Irradiation  Laboratory) in the CNR Campus of Pisa which
has been operating for more than 20 years with scientific output and
international collaboration making ILIL a primary reference in the domain of
laser-plasmas. AG is author of more than 200 papers published on international
refereed journals, mainly in the field of laser and plasma physics, plasma
instabilities relevant to Inertial Fusion, radiation from plasmas, laser-driven
particle acceleration and their biomedical potential. AG has organized and
chaired a large number of international conferences on these topics. He is
member of the International Advisory Board of the International Conference on
High Energy Density Science, annually held in Yokohama. His research group has
been supported by CNR, Italian Ministry of Education, Italian Ministry of
Health, European Union, Extreme light Infrastructure (ELI), CEA (France), JSPS
(Japan). AG has been very active in teaching and tutoring students and young
scientists. Young scientists trained in the AG' lab are today Professors or
Researchers in prestigious Universities or Research Institutions, including
Universities of Pisa, Siena, Milano, Bordeaux, Oxford, Belfast, Ecole
Polytechnique in Palaiseau, CEA-Saclay, BMI-Berlin, Rutherford Appleton
Laboratory. In the last ten years 2006-2015 AG devoted most of his work at
studying possible medical uses of laser-driven particle accelerators.  Experiments performed in Pisa and at
CEA-Saclay led to the discovery of a high efficiency acceleration regime
allowing the production of electron bunches whose charge and kinetic energy are
suitable for radiotherapy. Those electrons were also used to drive a gamma
sources and produce photo-activation, so opening a perspective of interest for
nuclear medicine. In the meantime AG promoted R&D studies to achieve a
practical usability of laser-driven accelerators in radiobiology and clinics, also
in collaboration with CEA-Saclay and University of Osaka. In this framework he
recently published (2015) a review paper on “Laser-Plasma Particle Sources for
Biology and Medicine”. 



Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

13.05.2016

Abbildungen

XVIII, 320 p. 106 illus., 78 illus. in color.

Herausgeber

Antonio Giulietti

Verlag

Springer

Seitenzahl

320

Maße (L/B/H)

24,1/16/2,4 cm

Gewicht

676 g

Auflage

1st ed. 2016

Sprache

Englisch

ISBN

978-3-319-31561-4

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Laser-Driven Particle Acceleration Towards Radiobiology and Medicine
  • Produktbild: Laser-Driven Particle Acceleration Towards Radiobiology and Medicine
  • From the Contents: Part I Laser driven particle acceleration: From experiments to devices.- Ultra-intense lasers and particle acceleration: past, present and future.- Part II Biophysical studies with laser driven particle sources.- Part III Synchrotron, ion accelerator and microbeam.- Synchrotron source: dosimetry and pre-clinical trials.